Yoshihiko Tomita
11PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Aug 07, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial.Matthew D Galsky, Dean F Bajorin, Yoshihiko Tomita
|Jan 24, 2025
Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP.Kaede Hiruma, Vladimir Bilim, Akira Kazama
|Jan 16, 2025
First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.Hsiao-Jen Chung, Chihiro Kondoh, Woo Kyun Bae
|Dec 19, 2023
Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART).Taigo Kato, Yuzo Nakano, Fumiya Hongo
|Dec 08, 2023
Arteriolar hyalinization at 0-hour biopsy predicts long-term graft function in deceased kidney transplantation.Masaki Murata, Masayuki Tasaki, Kazuhide Saito
|Aug 02, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.Leandro Blas, Masaki Shiota, Hideaki Miyake
Pageof 2
Frequent Collaborators
2 joint publications
Hirotsugu Uemura
2 joint publications
Masaki Murata
1 joint publications
Go Kimura
1 joint publications
Satoshi Fukasawa
1 joint publications
Kazuyuki Numakura
1 joint publications
Yutaka Sugiyama
1 joint publications
Kazutoshi Yamana
1 joint publications
Sei Naito
1 joint publications
Andrea Necchi
1 joint publications
Yohei Tajima
